TO-O-1001

N/A

Report date: 2025/12/10 17:22:05
NME

Base Information

Drug NameTO-O-1001
Drug Alias NameTO-O-1001MG-O-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 1 inhibitors
TargetsRho-associated protein kinase 1
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTheratocular Biotek Co LtdMetagone Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesTheratocular Biotek Co Ltd
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A